Intent to Sole Source - Reagents and Consumables required for Systemic Autoimmune Rheumatic Diseases.
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH), on behalf of the Critical Care Medicine Department, intends to award a firm-fixed-price sole source contract to 10X Genomics Inc. for reagents and consumables required for Systemic Autoimmune Rheumatic Diseases research. This is a Notice of Intent, not a request for proposal. Interested parties may submit capability statements by June 2, 2026.
Scope of Work
The acquisition covers specific reagents and consumables from 10X Genomics, Inc., essential for the Chromium platform used in Systemic Autoimmune Rheumatic Diseases research. The required items include:
- Library Construction Kit, 16 rxns: 4 units
- Chromium Single Cell Human BCR Amplification Kit, 16 rxns: 2 units
- Chromium Single Cell Human TCR Amplification Kit, 16 rxns: 2 units
- Chromium Next GEM Chip K Single Cell Kit, 48 rxns: 1 unit
- Chromium™ Next GEM Single Cell 5' Kit v2, 16 rxns: 2 units
- Shipping & Handling The total estimated project cost is $42,808.00.
Contract & Timeline
- Contract Type: Firm-Fixed Price
- Proposed Contractor: 10X Genomics, Inc., Pleasanton, California
- Statutory Authority: 41 U.S.C. 253(c)(1) as implemented by FAR 6.302-1 (only one responsible source)
- Response Due: June 2, 2026, 12:00 PM Eastern Standard Time
- Published Date: May 18, 2026
Justification for Sole Source
The reagents are proprietary and exclusively compatible with the 10X Genomics Chromium platform. Substitution would disrupt ongoing experiments, compromise data accuracy, and hinder critical research into early biomarkers and mechanisms of lung diseases. Market research identified 10X Genomics as the sole source provider.
Action Items
This is not a request for proposal. All responsible sources that believe they can provide the required items may submit a capability statement via email to valerie.gregorio@nih.gov by the due date. The subject line must reference NOI-CC-OLAO-26-006103. A determination not to compete this requirement, based on responses, is solely at the Government's discretion.